Fidelity International
DXCM icon

Fidelity International’s DexCom DXCM Stock Holding History

Fidelity International’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.6M Buy
558,462
+56,110
+11% +$3.74M 0.03% 397
2026
Q1 		$31.5M Sell
502,352
-90,610
-15% -$6.31M 0.02% 421
2025
Q4 		$39.4M Buy
592,962
+6,332
+1% +$409K 0.03% 382
2025
Q3 		$39.5M Sell
586,630
-458,430
-44% -$36.3M 0.03% 384
2025
Q2 		$91.2M Buy
1,045,060
+602,785
+136% +$47.2M 0.08% 237
2025
Q1 		$30.2M Buy
442,275
+204,999
+86% +$16.7M 0.03% 397
2024
Q4 		$18.5M Sell
237,276
-2,655
-1% -$197K 0.02% 456
2024
Q3 		$16.1M Buy
239,931
+236
+0.1% +$19.4K 0.01% 490
2024
Q2 		$27.2M Buy
239,695
+51,975
+28% +$6.57M 0.03% 412
2024
Q1 		$26M Buy
187,720
+1,358
+0.7% +$171K 0.03% 405
2023
Q4 		$23.1M Buy
186,362
+102,213
+121% +$10.4M 0.02% 398
2023
Q3 		$7.85M Sell
84,149
-20,216
-19% -$2.28M 0.01% 514
2023
Q2 		$13.4M Sell
104,365
-3,467
-3% -$419K 0.02% 470
2023
Q1 		$12.5M Sell
107,832
-3,495
-3% -$391K 0.01% 459
2022
Q4 		$12.6M Sell
111,327
-96,621
-46% -$10.6M 0.02% 462
2022
Q3 		$16.7M Sell
207,948
-75,439
-27% -$6.39M 0.02% 416
2022
Q2 		$21.1M Sell
283,387
-118,345
-29% -$10.8M 0.03% 401
2022
Q1 		$51.4M Buy
+401,732
New +$43.9M 0.05% 293
2021
Q2 		– Sell
-12
Closed -$1K – 914
2021
Q1 		$1K Hold
12
– – ﹤0.01% 897
2020
Q4 		$1K Sell
12
-4
-25% -$357 ﹤0.01% 865
2020
Q3 		$2K Hold
16
– – ﹤0.01% 829
2020
Q2 		$2K Buy
+16
New +$1.43K ﹤0.01% 809
2015
Q4 		– Sell
-115,928
Closed -$2.49M – 497
2015
Q3 		$2.49M Sell
115,928
-68,208
-37% -$1.52M 0.01% 428
2015
Q2 		$3.68M Buy
+184,136
New +$3.23M 0.01% 440

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity International's DXCM Position: Q2 2026 in Review

Fidelity International increased its DexCom (DXCM) stake by 11% in Q2 2026, buying an estimated $3.74M and bringing the position to 558,462 shares worth $37.6M. The position accounts for 0.03% of the portfolio, ranked #397.

Fidelity International first reported a position in DXCM in Q2 2015 and has held it in 24 quarters since. The position peaked at $91.2M in Q2 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Fidelity International held 558,462 shares of DexCom worth $37.6M as of Q2 2026.
  • Fidelity International bought 56,110 DexCom shares in Q2 2026, an estimated $3.74M.
  • DexCom made up 0.03% of Fidelity International's portfolio in Q2 2026, its #397 holding.
  • Fidelity International first reported a position in DexCom in Q2 2015 and has held it in 24 quarters since.
  • Fidelity International's DexCom position peaked at $91.2M in Q2 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.